WISCONSIN – Today, U.S. Senator Tammy Baldwin hosted a press conference to celebrate the $49 million investment she secured for Wisconsin’s Tech Hub to grow the state’s personalized medicine and biohealth sector – advancing research and innovation, growing our economy and creating jobs, and boosting American competitiveness in a cutting-edge industry. Senator Baldwin was joined on the call by Wisconsin Economic Development Corporation CEO and Secretary Missy Hughes, BioForward Wisconsin CEO Lisa Johnson, and Rockwell Automation CEO Blake Moret.
WATCH: Senator Baldwin hosts press conference on new investment for Wisconsin’s Biohealth Tech Hub
The $49 million in funding, which was made available through the Baldwin-backed CHIPS and Science Act, will allow Wisconsin’s consortium of public and private partners to boost research and expand lab space, increase coordination and collaboration, improve access to capital to start and grow businesses, and further build out the personalized medicine and biohealth technology sector. Personalized medicine is a medical approach that tailors prevention and treatment to the individual characteristics of each patient, including using genetic makeup, medical history, and environmental and lifestyle information to improve patient outcomes.
